Flash CGM Is Associated With Reduced Diabetes Events and Hospitalizations in Insulin-Treated Type 2 Diabetes.

Richard M BergenstalMatthew S D KerrGregory J RobertsDiana SoutoYelena NabutovskyIrl B Hirsch

Published in: Journal of the Endocrine Society (2021)

Acquisition of the flash CGM system was associated with reductions in ADE and ACH. These findings provide support for the use of flash CGM in type 2 diabetes patients treated with short- or rapid-acting insulin therapy to improve clinical outcomes and potentially reduce costs.

Keyphrases

type diabetes
glycemic control
cardiovascular disease
insulin resistance
adipose tissue
skeletal muscle
metabolic syndrome
bone marrow
mesenchymal stem cells
sensitive detection